HOME >> MEDICINE >> NEWS
Optimal treatment of carpal tunnel syndrome

Carpal tunnel syndrome (CTS) is the most recognized occupational maladies as well as one of the most reported. Marked by numbness, weakness, and pain in the wrist and hand particularly the thumb and index finger, and frequently shooting up the arm CTS occurs when the median nerve, which runs from the forearm to the base of the palm, becomes compressed. This constriction or pinching is commonly attributed to repetitive motion and stress. Yet, in spite of its association with heavy computer use, carpal tunnel syndrome is not confined to data entry workers. Butchers, mechanics, musicians, dental hygienists, tennis players and golfers are vulnerable. According to recent studies, CTS affects about 3 percent of the general population, whether on the job or at play. Women are more likely than men to develop it. Individuals with rheumatoid arthritis are also at high risk.

Despite the prevalence of CTS and its considerable economic impact in terms of both worker absenteeism and compensation claims there is no universally accepted therapy. Mild cases are usually left untreated. Moderate cases may be treated with local injections of corticosteroids, if patients fail to respond to splinting and anti-inflammatory drugs like ibuprofen. In severe cases, with the threat of permanent loss of sensation, the preferred treatment is surgery. Surgery, however, is often recommended to patients before trying less invasive and less expensive treatments. Is surgery always the best course for carpal tunnel syndrome's sufferers? A team of researchers in Madrid recently set out to find the answer. The results of their clinical trial, published in the February 2005 issue of Arthritis & Rheumatism (http://www.interscience.wiley.com/journal/arthritis), suggest that local steroid injection is just as effective as surgery for the long-term symptom
'"/>

Contact: Amy Molnar
amolnar@wiley.com
John Wiley & Sons, Inc.
3-Feb-2005


Page: 1 2 3

Related medicine news :

1. Optimal time to treat migraine pain with Relpax; is early in the attack, new study finds
2. Hormonal treatment improves survival in high-risk prostate cancer patients
3. Chronic pain treatments more effective when taken together, new study shows
4. Brain activity prior to treatment flags vulnerability to antidepressant side effects
5. Cultural and social factors influence prostate cancer treatment
6. Research offers hope of new treatments for liver damage
7. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
8. Stanford patient is first to test new treatment for peripheral arterial disease
9. Scientist works on innovative treatments for brain tumors
10. Blacks less likely to get expensive, newer heart treatments
11. Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many ... event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids ... of all ages; it is a non-competitive, non-timed event, which is all about having ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
Breaking Medicine Technology:
Cached News: